Prognostic factors and response monitoring after CD19-directed CAR T-cell therapy in diffuse large B-cell lymphoma: a time-resolved review

Authors

Yi Xiao (ORCID: https://orcid.org/0000-0001-7274-6774)
Shuai Su (ORCID: https://orcid.org/0000-0002-9418-6592)
Jiaying Wu (ORCID: https://orcid.org/0000-0002-8708-9743)

Institutions

Tongji Hospital (CN)
Huazhong University of Science and Technology (CN)

Publication Details

Journal: Journal of Translational Medicine
Published: 2026-11-02
DOI: https://doi.org/10.1186/s12967-026-09172-0
Primary Topic: CAR-T cell therapy research
Type: article
Field-Weighted Citation Impact: 0.00

Funders

National Natural Science Foundation of China

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Prognostic factors and response monitoring after CD19-directed CAR T-cell therapy in diffuse large B-cell lymphoma: a time-resolved review

Yi Xiao, Shuai Su, Jiaying Wu

Nov 2, 2026

3 links

Journal of Translational Medicine

CAR-T cell therapy research

article

Prognostic factors and response monitoring after CD19-directed CAR T-cell therapy in diffuse large B-cell lymphoma: a time-resolved review

Yi Xiao, Shuai Su, Jiaying Wu

November 2, 2026article en

Abstract

No abstract available for this paper.

Journal of Translational Medicine

Tongji Hospital (CN), Huazhong University of Science and Technology (CN)

National Natural Science Foundation of China

Good health and well-being

Openalex Percentile: Top 17%

CAR-T cell therapy research

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon

Prognostic factors and response monitoring after CD19-directed CAR T-cell therapy in diffuse large B-cell lymphoma: a time-resolved review — Yi Xiao, Shuai Su, et al. · Journal of Translational Medicine (2026) | TGRS Research Map | TGRS